Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Bone. 2012 Oct 16;54(2):222–229. doi: 10.1016/j.bone.2012.10.008

Fig. 5.

Fig. 5

Percentage change in serum FGF23 as determined by the C-terminal (a) and Intact (b) Immutopics assays in pediatric dialysis patients treated for 8 months with 1αD2+CaCO3 (closed diamonds), 1αD2+sevelamer (open diamonds), calcitriol+CaCO3 (closed squares), and calcitriol+sevelamer (open squares). Asterisk indicates p<0.01 from baseline. 1αD2, doxercalciferol; CaCO3, calcium carbonate.